Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 6, 2020; 8(1): 46-53
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.46
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.46
Potential role of the compound Eucommia bone tonic granules in patients with osteoarthritis and osteonecrosis: A retrospective study
Cheng-Xia Hu, Department of Pain, Haiyang People’s Hospital, Yantai 265100, Shandong Province, China
Ke-Yao Hu, Department of Urology, Yantaishan Hospital, Yantai 264001, Shandong Province, China
Jian-Feng Wang, Department of Pain, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
Author contributions: Hu CX designed and performed the research; Hu KY analyzed the data; Wang JF wrote the paper.
Institutional review board statement: This study was reviewed and approved by the Medical Ethics Committee of Qilu Hospital of Shandong University.
Informed consent statement: All patients in our study provided informed consent.
Conflict-of-interest statement: The authors declare having no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Jian-Feng Wang, MD, Attending Doctor, Department of Pain, Qilu Hospital of Shandong University, No. 107, Wenhua West Road, Jinan 250012, Shandong Province, China. 18714779474@163.com
Received: October 28, 2019
Peer-review started: October 28, 2019
First decision: November 13, 2019
Revised: November 19, 2019
Accepted: November 23, 2019
Article in press: November 23, 2019
Published online: January 6, 2020
Processing time: 70 Days and 20.9 Hours
Peer-review started: October 28, 2019
First decision: November 13, 2019
Revised: November 19, 2019
Accepted: November 23, 2019
Article in press: November 23, 2019
Published online: January 6, 2020
Processing time: 70 Days and 20.9 Hours
Core Tip
Core tip: Eucommia enhances the curative effect of meloxicam, and combining Eucommia and meloxicam is effective for the treatment of osteoarthritis and osteonecrosis.